Introduction
Central core disease (CCD) was the ®rst congenital muscle disorder described involving structural changes of the muscle ®bres (Shy and Magee, 1956; Green®eld et al., 1958) . It is generally considered as one of the most frequent congenital myopathies (Fardeau and Tome Â, 1994) . The clinical phenotype is classically described as relatively benign and nonprogressive with mild hypotonia during early childhood, delayed motor milestones, diffuse and moderate muscle weakness and gracility, frequent spinal deformities, hip dislocation, arched feet and pectus excavatus. A large phenotypic variability has been demonstrated from the early descriptions, but mainly to emphasize the frequency of mild, almost asymptomatic forms (Fardeau and Tome Â, 1994) .
The histological hallmark of this disorder is the presence of well-limited rounded areas of abnormal myo®brillary architecture, with a variable degree of sarcomeric disorganization and absence of mitochondria, allowing an easy detection of the cores on oxidative enzyme stainings in transverse cryostat sections. Several morphological aspects of the cores have been described in CCD patients: classical or typical`central cores',`eccentric cores' and variants associating single or multiple`peripheral or central cores' in the same muscle ®bre (Monnier et al., 2001; De Cauwer et al., 2002) . In all cases, the cores had abrupt borders with the normal regions of the muscle ®bres, and they extended almost along the full length of the ®bre.
CCD has been considered to be generally transmitted according to an autosomal dominant (AD) inheritance. Linkage analysis (Haan et al., 1990) mapped the locus to chromosome 19q13, and association with malignant hyperthermia susceptibility (MHS) subsequently led to the identi®cation of mutations in the ryanodine receptor gene (RYR1) for~40% of CCD families (Lynch et al., 1999; Monnier et al., 2000 Monnier et al., , 2001 . The majority of the CCD mutations have been found in the C-terminal part of the protein (Lynch et al., 1999; Monnier et al., 2000 Monnier et al., , 2001 Tilgen et al., 2001; Davis et al., 2003) , and functional studies have con®rmed the pathogenic role of the RYR1 mutations in some of them (Lynch et al., 1999; Monnier et al., 2000; Tilgen et al., 2001; Dirksen and Avila, 2002 ). An autosomal recessive (AR) inheritance of RYR1 mutations was shown recently in two unrelated families (Ferreiro et al., 2002; Jungbluth et al., 2002) .
In the last 20 years, from a total series of 70 CCD families, we have studied seven cases of CCD, belonging to six families, presenting with a fetal akinesia syndrome. Histopathological analysis showed large eccentric unstructured cores in the muscle ®bres. Molecular genetic studies allowed the identi®cation of mutations in the RYR1 gene in three out of the four families for which the samples were available for extensive molecular studies. Three patients from two unrelated AR families were compound heterozygous and one patient from an AD family was heterozygous, supporting an involvement of the RYR1 gene in fetal akinesia associated with CCD.
Subjects and methods
We analysed the clinical, histochemical, ultrastructural and genetic data of seven patients (fetuses/infants) from six unrelated families. Eight muscle biopsies (case 1 from family I had two muscle biopsies) were studied with histochemical and ultrastructural techniques. The molecular analysis of the RYR1 gene could only be performed in the four families whose DNA or RNA samples were available. This study was authorized by the ethical committee of Pitie Â-Salpe Ãtrie Áre Hospital (CCPPRB) and the DRC of the Assistance Publique, Ho Ãpitaux de Paris.
Subjects

Family I, cases 1 and 2
This was a non-consanguineous family with one affected child and one affected fetus who died at 32 weeks of gestation age. There were no neuromuscular familial antecedents. The mother was completely asymptomatic and the father presented a discrete facial hypomimia without any skeletal muscle weakness. Open deltoid muscle biopsies were performed in both parents and did not show any structural abnormality (Fig. 1) .
Case 1 was a boy born at 37 weeks. A hydramnion was noted during pregnancy; a normal chromosome chart was established by amniocentesis. At birth: weight, 2500 g; head circumference, 34.5 cm; Apgar score, 6/8; immediate respiratory distress requiring mechanically assisted ventilation. Complete generalized hypotonia, absence of spontaneous movements, thin muscular masses and facial hypomimia : linkage analysis performed with microsatellite markers¯anking the RYR1 locus on chromosome 19q13.1 showed that the two affected children carried the same haplotypes inherited from their unaffected parents. Oxidative staining (NADH-TR) on transverse muscle sections from the propositus (case 1, at 15 days and at 1 year of age) showed large eccentric cores, while muscle sections from both asymptomatic parents were histologically normal.
were the major clinical features. Multiple malformations were present: short femurs, facial dysmorphism with retrognathia and hypotelorism, and bilateral clinodactyly of the second and ®fth ®ngers. During the ®rst 6 months of life, he showed complete respiratory dependence and needed permanent ventilation through a tracheotomy. Awakening was normal, but severe global hypotonia persisted. During infancy, he developed a craniostenosis and an early kyphoscoliosis; spinal MRI showed a vertebral malformation in D4±D5 without medullar compression.
At 2 years, the tracheotomy-assisted ventilation was continued in hospital care. The infant improved his motor development but with persistence of severe muscular weakness and amyotrophy: he was able to sit without assistance at 22 months of age and to move in a sitting position from 28 months of age. Scoliosis was corrected by an orthopaedic corset and physiotherapy. In spite of the tracheotomy, he acquired language towards the age of 3 years although facial weakness was still present. He progressively developed a bilateral ptosis and strabismus (Fig. 2) . Muscle biopsies were performed at 15 days and 1 year of life (Fig. 1) .
From 2 to 9 years of age, partial respiratory autonomy was acquired allowing diurnal weaning. He had good thoracic growth, indicating that closure of the tracheotomy could be planned in the years to come. There was good control of the deformation of the rachis thanks to orthopaedic and physical care, but his muscles remained severely atrophic. There was a normal growth of the cranial perimeter and a normal echocardiographic follow-up. He started walking with assistance at 5 years of age, and without assistance 6 months later. Normal schooling took place successfully.
Case 2, the younger brother of case 1, was an affected male fetus who died at 32 weeks of gestation. Frequent echography surveillance was performed during the pregnancy, since the family had an antecedent of severe CCD congenital myopathy. During the second and third trimester of pregnancy, large hydramnion, absence of fetal movements and multiple malformations were noted. An interruption of the pregnancy was performed in accordance with ethical regulations, and a muscle biopsy was analysed.
Family II, case 3
This was a non-consanguineous family with one affected female child and one non-affected male child. There were no neuromuscular antecedents. The parents were asymptomatic.
During the pregnancy, at 36 weeks of gestation, poor fetal movements and hydramnion were noted. At 37 weeks, a Caesarean section was performed due to a breech presentation. At birth, the infant presented global hypotonia with frog position, no spontaneous antigravity movements and multiple arthrogryposis with left hip and knee blocked, bilateral valgus feet, adductus thumb and left femur fracture. A dysmorphic face with retrognathism was associated. Permanent ventilatory assistance was necessary during the ®rst month of life. She presented serious swallowing dif®culties and was kept at the hospital until 5 months of age. A muscle biopsy was performed at 2 months of age (Fig. 3) . During the ®rst year of life, there were persistent hypotonia, weakness and muscular hypotrophy; swallowing function improved. From an early age, she developed bilateral ptosis and strabismus. Intensive orthopaedic care and physical therapy were performed during infancy. At 5 years of age, she could crawl on the¯oor but not walk unsupported. A normal schooling was adapted successfully. 
Family III, case 4
This was a non-consanguineous family with one affected girl presenting with a severe form of CCD. The mother, a 17 year old, presented with a classic form of CCD. After a high-risk pregnancy and premature delivery, the child was born at 34± 35 weeks of gestation with a weight of 1860 g. She presented at birth with severe hypotonia, thin ribs, swallowing dif®culty, respiratory distress and cyanosis needing mechanical assistance from the second day of life. A muscle biopsy was performed at 8 days of life. She needed permanent mechanically assisted ventilation, and died at 8 days of age.
Family IV, case 5
This was a non-consanguineous family with one affected boy born after Caesarean section. Permanent respiratory assistance was needed from birth until death at 10 months of life. A muscle biopsy was performed at 10 months of life.
Family V, case 6
This was a non-consanguineous family with one affected girl. Hydramnion and fetal akinesia were noted during gestation. At birth, she was diagnosed as having a Pena±Shokeir syndrome, with multiple arthrogryposis, facial dysmorphism, microretrognathia, diffuse amyotrophy and lung hypoplasia. She needed respiratory assistance from birth, and died at 1 month of age (Fig. 4) . A muscle biopsy was performed at 1 month of age.
Family VI, case 7
This was a non-consanguineous family with one affected fetus presenting with multiple arthrogryposis detected by echography, facial malformations and diffuse amyotrophy. An interruption of the pregnancy was performed at 30±31 weeks of gestation, in accordance with ethical regulations, and a muscle biopsy was performed.
Histopathological studies
Skeletal muscle biopsies were analysed in seven patients (fetuses/infants) and in the two parents from family I. Parts of each muscle biopsy were frozen immediately in isopentane cooled in liquid nitrogen and stored at ±80°C until processing, and another specimen was ®xed for ultrastructural analysis. For three patients, a small specimen was frozen immediately in liquid nitrogen for RNA extraction. Histo-enzymological studies were carried out on 10 mm transverse cryostat sections according to protocols described previously (Romero et al., 1993) . For the two dead fetuses (cases 2 and 7), immediate post-delivery muscle biopsies were taken.
Molecular genetic studies Haplotyping analysis
A haplotyping study was performed in family I as described previously (Monnier et al., 2000) in chromosome 19q13.1 that includes the RYR1 gene. The following markers were used: D19S220, D19S909, RYR1, D19S422 and D19S417.
RYR1 mutation screening
Total RNA was extracted from frozen muscle specimens using a guanidium thiocyanate±phenol±chloroform method. First-strand cDNA was synthesized from total RNA using speci®c primer mixes and Long Expand Reverse Transcriptase (Roche, Switzerland) and then ampli®ed in 31 overlapping fragments using Taq Plus Precision Polymerase (Stratagene, La Jolla, CA). The ampli®ed products spanning the entire RYR1 cDNA subsequently were puri®ed and directly sequenced. When muscle samples were unavailable, RYR1 mutation screening was performed on genomic DNA extracted from blood samples using standard procedures. Exons 92±106 coding for the calcium channel domain and exons involved in the MH1 and MH2 domains were analysed by denaturating high-performance liquid chromatography (dHPLC). Exons showing a variation were then sequenced.
Mutation analysis
Mutation analysis was performed in the probands' families and on 100 chromosomes from the general population. The G215E and G4899E mutations were screened, respectively, using dHPLC analysis of exon 8 and exon 102. BstUI and BstNI analysis of exon 95 and exon 97 was used to screen for the L4650P mutation and the K4724Q mutation, respectively. Both mutations created a restriction site. Fragment sizes obtained after enzymatic digestion were analysed by electrophoresis on acrylamide gels.
Results
Clinical and histopathological data
All patients (four males and three females) presented with a fetal akinesia syndrome and hydramnion during pregnancy.
Two fetuses died after interruption of the pregnancy at 32 and 30±31 weeks of gestation, and ®ve children were born with severe hypotonia and arthrogryposis. Among the children living at birth, three died at an early age (8 days, 30 days and 10 months of life) and two are still alive, at 5 and 9 years of age, after a long period of intensive care and respiratory assistance (cases 1 and 3). In spite of the severe hypotonia and hypotrophy, failure to thrive and severe malformations at birth (multiple arthrogryposis, congenital dislocation of the hips, severe hypotonia, skeletal and feet deformities, and kyphoscoliosis), the two surviving children improved their motor milestones and had a normal intellectual development. The muscular weakness appeared to be`non-progressive'; there was no cardiac involvement and the respiratory capacities were acceptable for their respective ages. It should be noted that, from an early age, bilateral ptosis and strabismus was observed in both surviving patients (Fig. 2) . Clinical features are summarized in Table 1 .
Skeletal muscle biopsies were taken from all cases. The age at muscle biopsy ranged from 30±31 weeks of gestation to 1 year of age (Table 1 ). The diagnosis of CCD was shown on transverse muscle cryostat sections, which showed large, eccentric, well-limited areas devoid of any oxidative activity. The most frequent pattern was`unique large eccentric cores' in most muscle ®bres (Figs 1, 3 and 4) . In all cases, a (Figs 1, 3 and 4) . In all cases, ultrastructural analysis demonstrated large well-delimited areas with sarcomeric disorganization, myo®brillar compaction and absence of mitochondria, characteristic of non-structured cores (Fig. 4) . Details of the histological ®ndings are summarized in Table 1 .
Molecular genetics studies
Molecular genetic studies allowed the identi®cation of mutations in the RYR1 gene in families I, II and III. Two compound heterozygous mutations were identi®ed in two unrelated AR affected children and a heterozygous mutation was identi®ed in an AD affected child.
Family I (AR)
A preliminary linkage study performed with microsatellite markers¯anking the RYR1 locus on chromosome 19q13.1 showed that the two affected children carried the same haplotypes inherited from their unaffected parents. Sequencing of the entire RYR1 cDNA from one affected boy led to the identi®cation of two mutations in the RYR1 gene. A R614C mutation at the amino acid level was identi®ed in exon 17 of the maternal allele. A G215E mutation was identi®ed in exon 8 of the paternal allele. These two mutations were present in both affected children. The R614C mutation is the most frequent mutation identi®ed in the French population affected by MHS. The G215E mutation affected a very well conserved glycyl residue localized in the N-terminal domain of the protein; it introduced a negative charge and was absent in 100 chromosomes from the general population. This change was inherited from the father, who was clinically and histologically unaffected (Fig. 1) .
Family II (AR)
Sequencing of the entire RYR1 cDNA from the affected girl led to the identi®cation of two mutations in the RYR1 gene, a L4650P mutation in exon 95 and a K4724Q mutation in exon 97. The L4650P mutation affected a well-conserved leucine localized in the M6 transmembrane region of the protein, while the K4724Q mutation affected a well-conserved lysyl residue that mapped to the cytoplasmic loop M6±M7 according to the recently described calcium channel topology (Du et al., 2002) . Both mutations were absent from 100 chromosomes analysed from the general population. The K4724Q mutation was inherited from the proband's father and the L4650P mutation from her mother. Both parents were clinically unaffected. Unfortunately, no muscle samples were available for histological studies.
Family III (AD)
Since a muscle sample was unavailable for mutation screening, genomic DNA was investigated using dHPLC screening of the C-terminal domain containing the calcium channel (exons 92±106). Furthermore, exons involved in known MHS domains were screened using dHPLC. A G4899E mutation in exon 102 of the RYR1 gene was identi®ed in the severely affected newborn. Her less severely affected mother transmitted this mutation. The mutation affected the last glycyl residue of a very well conserved GVRAGGGIGD luminal motif (amino acids 4891±4900) that was proposed as a pore-forming fragment (Zhao et al., 1999) .
Family VI (sporadic)
Sequencing of the entire RYR1 cDNA from the affected fetus did not allow the identi®cation of mutations in the RYR1 gene.
Families IV and V
For the two remaining sporadic cases, neither probands' biological samples were available for molecular investigation.
Discussion
Fetal akinesia syndrome is an aetiologically heterogeneous group of development abnormalities resulting from a lack of intra-uterine fetal movements (Hammond and Donnenfeld, 1995; Fallet-Bianco, 1997) . This group includes cases previously known as Pena±Shokeir syndrome (Pena and Shokeir, 1976; Brueton et al., 2000; Ho, 2000) . The fetal akinesia syndrome is well known in several congenital myopathies such as nemaline and myotubular myopathies, but as yet has not been associated with CCD (Lammens et al., 1997; Mulder et al., 2001; Biancalana et al., 2003) . The classic description of CCD patients includes delayed motor milestones, hypotonia during infancy and diffuse muscle weakness with reduced muscle bulk. Here, we describe à severe neonatal form' of CCD with antenatal onset of symptoms; all cases (four males and three females) presented with fetal akinesia, multiple arthrogryposis and hydramnion during pregnancy. At birth, the clinical picture was completed by severe hypotonia and respiratory distress, frequently often associated with multiple malformations. The prognosis was most often severe, but two patients (cases 1 and 3) survived after long-term ventilatory assistance and nursing care. In these two children, the muscle weakness remained apparently stable and`non-progressive', and they were able to follow normal schooling. It is also important to note that both surviving children developed bilateral ptosis and strabismus during infancy; it is interesting that these particular ocular manifestations occurred in patients presenting compound heterozygous RYR1 gene mutations (Table 1 and Fig. 2 ).
Ocular symptoms are quite uncommon and have rarely been described in CCD patients (Shuaib et al., 1987) .
The diagnosis of CCD was suggested following the examination of transverse muscle cryostat sections with oxidative enzyme staining that showed well-limited`unique large eccentric cores' in the muscle biopsies. This pathological pattern was particularly evident in this group of CCD patients (Figs 1, 3 and 4) . The diagnosis was con®rmed by an ultrastructural study that showed non-structured core areas. As usual in congenital myopathies, all muscle biopsies showed a type I ®bre predominance. Noticeably, three of the muscle biopsies (cases 1, 3 and 6) also showed a signi®cant increase in the endomysial connective tissues that could lead to diagnostic errors in incompletely studied cases (Figs 1, 3  and 4) .
Classically, CCD is an AD disorder associated with mutations mostly localized in the C-terminal domain of the RYR1 protein (Lynch et al., 1999; Monnier et al., 2000 Monnier et al., , 2001 Tilgen et al., 2001; Davis et al., 2003) . However, in the present study, a recessive inheritance was strongly suggested in ®ve unrelated families: I, II, IV, V and VI. Compound heterozygous mutations were identi®ed in families I and II. No other change was found after the sequencing of the entire RYR1 cDNA extracted from probands' muscles.
In family I, both affected children carried a R614C mutation on the maternal allele and a G215E mutation on the paternal allele. The mutations are localized in the N-terminal domain of the protein. The G215E mutation is a new mutation affecting a very well conserved amino acid among distant species and RYR1 isoforms. The R614C mutation is classically associated with the MHS phenotype, and its pathogenic effect on channel release activation by triggering agents has been well documented McCarthy et al., 2000) . Furthermore, we recently have identi®ed this mutation in a homozygous state or associated with another MHS mutation in MHS patients with no myopathic phenotype . To date, this mutation has never been associated with congenital myopathy phenotypes at either heterozygous, homozygous or compound heterozygous levels. To explain the severity of the disease observed in the two affected children, it will be necessary to evaluate the deleterious association of these two particular mutations in the holotetrameric RYR1 protein.
In family II, the affected child was a compound heterozygous for the L4650P and K4727Q mutations that mapped to the C-terminal calcium release channel. Both carrier parents were clinically unaffected. The L4650P mutation substitutes a well-conserved amino acid in the M6 transmembrane fragment according to the recently described calcium channel model (Du et al., 2002) . This region was found to be a hot spot for AD CCD mutations (unpublished observations). Although the carrier mother was clinically asymptomatic, no biopsy was available for morphological investigation. The paternal K4727Q mutation substitutes a well-conserved amino acid in mammalian in the M6±M7 cytoplasmic loop of the channel release domain. The association of these two vicinal changes could account for the severity of the clinical picture observed in the affected child.
A recessive inheritance, or sporadic disease, could also be suggested for families IV, V and VI. In family VI, sequencing of the complete cDNA extracted from a proband muscle biopsy failed to identify mutations in the RYR1 gene. This clearly raises the question of a possible genetic heterogeneity. Unfortunately, no biological samples were available to study families IV and V.
Family III represents a case of AD CCD in which a G4899E mutation in the RYR1 gene was identi®ed in the severely affected newborn and her less severely affected mother. The G4899E mutation substitutes a very well conserved amino acid located in the luminal GVRAGGGIGD pore-forming motif (Zhao et al., 1999) . This motif can be considered to be a hot spot for CCD mutations (Lynch et al., 1999; Monnier et al., 2001; Davis et al., 2003) . However, the severity of the disorder observed in the affected child compared with clinical pictures previously reported for patients mutated in this domain (Lynch et al., 1999; Monnier et al., 2001; Tilgen et al., 2001) suggests the implication of an additional factor. This factor could be a mutation in the paternal allele or a neomutation of the RYR1 gene not yet identi®ed due to the partial screening of the 106 exons present in the RYR1 gene. Alternatively, one cannot exclude a mutation in another gene of the triad junction. Unfortunately, no muscle sample was available for extensive cDNA investigation. Interestingly, an aggravation of the clinical phenotype through generations had also been reported previously in one family presenting with CCD associated with the RYR1 gene (Monnier et al., 2000) .
The diagnosis of CCD in these various families presenting with a fetal akinesia syndrome is supported by both histological studies and identi®cation of mutations in the RYR1 gene, previously associated with classical forms of CCD. Implication of the RYR1 gene as a main component of the pathogenic process was clearly suggested in three out of the four families investigated at the molecular level. In the absence of functional data on the different RYR1 mutations identi®ed in these children, functional studies are necessary to con®rm whether the RYR1 gene alone is fully responsible for this severe phenotype or is part of a multigenic process involving an additional aggravating factor that might explain the variable severity of CCD.
